Jung Eun Jang1,2, Han-Sol Park2, Hyun Ju Yoo2, In-Jeoung Baek2, Ji Eun Yoon2, Myoung Seok Ko2, Ah-Ram Kim2, Hyoun Sik Kim2, Hye-Sun Park2, Seung Eun Lee1,2, Seung-Whan Kim3, Su Jung Kim2, Jaechan Leem1, Yu Mi Kang1, Min Kyo Jung2, Chan-Gi Pack2, Chong Jai Kim2,4, Chang Ohk Sung4, In-Kyu Lee5, Joong-Yeol Park1, José C Fernández-Checa6,7, Eun Hee Koh1,2, Ki-Up Lee1,2. 1. Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea. 2. Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea. 3. Department of Pharmacology, University of Ulsan College of Medicine, Seoul, Republic of Korea. 4. Department of Pathology, University of Ulsan College of Medicine, Seoul, Republic of Korea. 5. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea. 6. Department of Cell Death and Proliferation, Biomedical Research Networking Center Consortium in Hepatic and Digestive diseases (CIBEREHD), Barcelona, Spain. 7. University of Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis, Keck School of Medicine, USC, Los Angeles, CA.
Abstract
Free cholesterol (FC) accumulation in the liver is an important pathogenic mechanism of nonalcoholic steatohepatitis (NASH). Plasmalogens, key structural components of the cell membrane, act as endogenous antioxidants and are primarily synthesized in the liver. However, the role of hepatic plasmalogens in metabolic liver disease is unclear. In this study, we found that hepatic levels of docosahexaenoic acid (DHA)-containing plasmalogens, expression of glyceronephosphate O-acyltransferase (Gnpat; the rate-limiting enzyme in plasmalogen biosynthesis), and expression of Pparα were lower in mice with NASH caused by accumulation of FC in the liver. Cyclodextrin-induced depletion of FC transactivated Δ-6 desaturase by increasing sterol regulatory element-binding protein 2 expression in cultured hepatocytes. DHA, the major product of Δ-6 desaturase activation, activated GNPAT, thereby explaining the association between high hepatic FC and decreased Gnpat expression. Gnpat small interfering RNA treatment significantly decreased peroxisome proliferator-activated receptor α (Pparα) expression in cultured hepatocytes. In addition to GNPAT, DHA activated PPARα and increased expression of Pparα and its target genes, suggesting that DHA in the DHA-containing plasmalogens contributed to activation of PPARα. Accordingly, administration of the plasmalogen precursor, alkyl glycerol (AG), prevented hepatic steatosis and NASH through a PPARα-dependent increase in fatty acid oxidation. Gnpat+/- mice were more susceptible to hepatic lipid accumulation and less responsive to the preventive effect of fluvastatin on NASH development, suggesting that endogenous plasmalogens prevent hepatic steatosis and NASH. CONCLUSION: Increased hepatic FC in animals with NASH decreased plasmalogens, thereby sensitizing animals to hepatocyte injury and NASH. Our findings uncover a novel link between hepatic FC and plasmalogen homeostasis through GNPAT regulation. Further study of AG or other agents that increase hepatic plasmalogen levels may identify novel therapeutic strategies against NASH. (Hepatology 2017;66:416-431).
Free cholesterol (FC) accumulation in the liver is an important pathogenic mechanism of nonalcoholic steatohepatitis (NASH). Plasmalogens, key structural components of the cell membrane, act as endogenous antioxidants and are primarily synthesized in the liver. However, the role of hepatic plasmalogens in metabolic liver disease is unclear. In this study, we found that hepatic levels of docosahexaenoic acid (DHA)-containing plasmalogens, expression of glyceronephosphate O-acyltransferase (Gnpat; the rate-limiting enzyme in plasmalogen biosynthesis), and expression of Pparα were lower in mice with NASH caused by accumulation of FC in the liver. Cyclodextrin-induced depletion of FC transactivated Δ-6 desaturase by increasing sterol regulatory element-binding protein 2 expression in cultured hepatocytes. DHA, the major product of Δ-6 desaturase activation, activated GNPAT, thereby explaining the association between high hepatic FC and decreased Gnpat expression. Gnpat small interfering RNA treatment significantly decreased peroxisome proliferator-activated receptor α (Pparα) expression in cultured hepatocytes. In addition to GNPAT, DHA activated PPARα and increased expression of Pparα and its target genes, suggesting that DHA in the DHA-containing plasmalogens contributed to activation of PPARα. Accordingly, administration of the plasmalogen precursor, alkyl glycerol (AG), prevented hepatic steatosis and NASH through a PPARα-dependent increase in fatty acid oxidation. Gnpat+/- mice were more susceptible to hepatic lipid accumulation and less responsive to the preventive effect of fluvastatin on NASH development, suggesting that endogenous plasmalogens prevent hepatic steatosis and NASH. CONCLUSION: Increased hepatic FC in animals with NASH decreased plasmalogens, thereby sensitizing animals to hepatocyte injury and NASH. Our findings uncover a novel link between hepatic FC and plasmalogen homeostasis through GNPAT regulation. Further study of AG or other agents that increase hepatic plasmalogen levels may identify novel therapeutic strategies against NASH. (Hepatology 2017;66:416-431).
Authors: Ju Huang; Cheryl L Birmingham; Shahab Shahnazari; Jessica Shiu; Yiyu T Zheng; Adam C Smith; Kenneth G Campellone; Won Do Heo; Samantha Gruenheid; Tobias Meyer; Matthew D Welch; Nicholas T Ktistakis; Peter Kijun Kim; Daniel J Klionsky; John H Brumell Journal: Autophagy Date: 2011-01-01 Impact factor: 16.016
Authors: Austin Nelson; Dawn M Torres; Ana E Morgan; Christopher Fincke; Stephen A Harrison Journal: J Clin Gastroenterol Date: 2009 Nov-Dec Impact factor: 3.062
Authors: H S Heymans; H vd Bosch; R B Schutgens; W H Tegelaers; J U Walther; J Müller-Höcker; P Borst Journal: Eur J Pediatr Date: 1984-04 Impact factor: 3.183
Authors: Laura Conde de la Rosa; Carmen Garcia-Ruiz; Carmen Vallejo; Anna Baulies; Susana Nuñez; Maria J Monte; Jose J G Marin; Lucia Baila-Rueda; Ana Cenarro; Fernando Civeira; Josep Fuster; Juan C Garcia-Valdecasas; Joana Ferrer; Michael Karin; Vicent Ribas; Jose C Fernandez-Checa Journal: J Hepatol Date: 2021-01-27 Impact factor: 30.083
Authors: Tagreed A Mazi; Kamil Borkowski; John W Newman; Oliver Fiehn; Christopher L Bowlus; Souvik Sarkar; Karen Matsukuma; Mohamed R Ali; Dorothy A Kieffer; Yu-Jui Y Wan; Kimber L Stanhope; Peter J Havel; Valentina Medici Journal: Free Radic Biol Med Date: 2021-06-25 Impact factor: 7.376
Authors: Sofia Kartsoli; Christina E Kostara; Vasilis Tsimihodimos; Eleni T Bairaktari; Dimitrios K Christodoulou Journal: World J Hepatol Date: 2020-08-27